Wealth Advisors of Iowa’s Lumos Pharma, Inc. Common Stock LUMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-11,699
| Closed | -$45.3K | – | 73 |
|
|
2024
Q3 | $45.3K | Hold |
11,699
| – | – | 0.02% | 69 |
|
|
2024
Q2 | $27.1K | Hold |
11,699
| – | – | 0.02% | 51 |
|
|
2024
Q1 | $33K | Hold |
11,699
| – | – | 0.02% | 61 |
|
|
2023
Q4 | $37.2K | Hold |
11,699
| – | – | 0.03% | 57 |
|
|
2023
Q3 | $38.6K | Hold |
11,699
| – | – | 0.03% | 57 |
|
|
2023
Q2 | $38.6K | Hold |
11,699
| – | – | 0.03% | 57 |
|
|
2023
Q1 | $38.7K | Hold |
11,699
| – | – | 0.03% | 55 |
|
|
2022
Q4 | $42.2K | Hold |
11,699
| – | – | 0.03% | 63 |
|
|
2022
Q3 | $104K | Sell |
11,699
-23,398
| -67% | -$194K | 0.1% | 54 |
|
|
2022
Q2 | $290K | Buy |
35,097
+23,398
| +200% | +$187K | 0.05% | 61 |
|
|
2022
Q1 | $110K | Hold |
11,699
| – | – | 0.06% | 60 |
|
|
2021
Q4 | $81K | Sell |
11,699
-61
| -0.5% | -$513 | 0.04% | 59 |
|
|
2021
Q3 | $112K | Hold |
11,760
| – | – | 0.06% | 56 |
|
|
2021
Q2 | $178K | Hold |
11,760
| – | – | 0.09% | 53 |
|
|
2021
Q1 | $138K | Hold |
11,760
| – | – | 0.08% | 52 |
|
|
2020
Q4 | $420K | Hold |
11,760
| – | – | 0.26% | 28 |
|
|
2020
Q3 | $163K | Hold |
11,760
| – | – | 0.11% | 30 |
|
|
2020
Q2 | $194K | Hold |
11,760
| – | – | 0.15% | 28 |
|
|
2020
Q1 | $100K | Buy |
+11,760
| New | +$164K | 0.08% | 26 |
|
Wealth Advisors of Iowa's LUMO Position: Q4 2024 in Review
Wealth Advisors of Iowa sold out of Lumos Pharma, Inc. Common Stock (LUMO) in Q4 2024, closing a stake of 11,699 shares — an estimated $45.3K sold.
Wealth Advisors of Iowa first reported a position in LUMO in Q1 2020 and held it in 19 quarters. The position peaked at $420K in Q4 2020. 0 funds tracked by Wall St. Rank hold LUMO as of Q4 2024.
- Wealth Advisors of Iowa reported no remaining Lumos Pharma, Inc. Common Stock position as of Q4 2024 after selling out during the quarter.
- Wealth Advisors of Iowa sold 11,699 Lumos Pharma, Inc. Common Stock shares in Q4 2024, an estimated $45.3K.
- Wealth Advisors of Iowa first reported a position in Lumos Pharma, Inc. Common Stock in Q1 2020 and held it in 19 quarters.
- Wealth Advisors of Iowa's Lumos Pharma, Inc. Common Stock position peaked at $420K in Q4 2020.
- 0 funds tracked by Wall St. Rank held Lumos Pharma, Inc. Common Stock as of Q4 2024.
Based on Wealth Advisors of Iowa's 13F filing for Q4 2024, filed 11 Feb 2025.